MT, M., GR, A., KH, L., RS, S., M, Ç., M, Z., . . . A, C. (2019). Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. Science advances, 5(9), eaaw9162. https://doi.org/10.1126/sciadv.aaw9162
Chicago Style (17th ed.) CitationMT, Manzari, et al. "Genomically Informed Small-molecule Drugs Overcome Resistance to a Sustained-release Formulation of an Engineered Death Receptor Agonist in Patient-derived Tumor Models." Science Advances 5, no. 9 (2019): eaaw9162. https://doi.org/10.1126/sciadv.aaw9162.
MLA (9th ed.) CitationMT, Manzari, et al. "Genomically Informed Small-molecule Drugs Overcome Resistance to a Sustained-release Formulation of an Engineered Death Receptor Agonist in Patient-derived Tumor Models." Science Advances, vol. 5, no. 9, 2019, p. eaaw9162, https://doi.org/10.1126/sciadv.aaw9162.